Healthcare Real-World Evidence Platform

Real-world evidence, or RWE, is clinical evidence about the use, benefits, and risks of a medical product or intervention derived from analyzing real-world data, or RWD, the data generated during routine care. That data comes from many sources: electronic health records, insurance claims, clinical registries, patient-generated and device data, and more. A real-world evidence platform is the software that makes generating RWE possible and credible. Its foundation is data aggregation and harmonization: bringing together disparate sources and mapping them to a common data model so they can be analyzed consistently, which is much of the technical challenge. On top of that, the platform supports cohort definition, rigorous analytics and epidemiological methods, and the data provenance and reproducibility that credible evidence requires. RWE increasingly informs regulatory decisions, payer coverage, and comparative effectiveness research. Because registries are a key RWD source, RWE platforms connect to clinical registry software. Done well, an RWE platform produces evidence rigorous enough to be trusted and defended, not just interesting charts.

Taction Software delivers RWE platforms as a full engagement shaped to your goals, whether you are a pharmaceutical or biotech company, a health economics and outcomes research team, a contract research organization, a payer, or an academic research group. We map your data sources, study questions, and regulatory context first, then build the modules that fit: data aggregation and integration, harmonization to common data models, data quality and provenance, cohort building, analytics and methods support, and reporting. Because harmonizing messy multi-source data is the core challenge, we draw on our data engineering and healthcare IT solutions practice. We build for methodological rigor and reproducibility, because RWE that cannot be defended has little value. We are candid that real-world data has limitations, and we design analyses to address confounding and bias rather than ignore them. Every module is composable, so you can start with data aggregation and a common data model and expand into advanced analytics over time. The goal is a platform that produces credible, defensible real-world evidence.

A purpose-built RWE platform delivers value that ad hoc data pulls and one-off analyses cannot, because credible evidence depends on harmonized data, rigorous methods, and reproducibility. The clearest benefit is decision-relevant evidence: RWE answers questions trials cannot, such as how a treatment performs across real, diverse populations and long time horizons. Harmonization to a common data model makes disparate sources analyzable together and analyses repeatable across studies. Data quality and provenance make the evidence defensible to regulators and payers, which is essential given RWE’s growing role in their decisions. Rigorous methods that address confounding and bias produce trustworthy conclusions rather than misleading correlations. Reproducible pipelines let studies be validated and reused, improving efficiency. For life sciences, RWE supports regulatory submissions, label expansions, and market access. For payers and researchers, it informs coverage and comparative effectiveness. Over time, a strong RWE platform becomes a reusable evidence-generation engine rather than a series of disconnected analyses.

Taction Software follows a rigor-first process suited to evidence that must withstand scrutiny. We begin with discovery, documenting your data sources, study questions, regulatory context, and methodological requirements. We then design the architecture: data aggregation, harmonization to an appropriate common data model, quality and provenance, cohort tooling, and analytics, with reproducibility built in. Development runs in iterative sprints with data science and epidemiology review, because RWE is as much about method as engineering. We invest heavily in data quality and harmonization, since evidence built on poorly harmonized or low-quality data is not defensible. We design analytics to address the real limitations of real-world data, including confounding and missingness, rather than producing naive correlations. Testing covers data integrity, harmonization accuracy, and analytic reproducibility. We deploy with governance and support ongoing studies. Throughout, we treat methodological rigor and data provenance as non-negotiable, because the entire value of RWE rests on whether the evidence can be trusted and defended.

RWE platforms integrate large, sensitive, multi-source data and produce evidence used in consequential decisions, so data engineering, privacy, and rigor are foundational. Taction Software builds on a HIPAA-aligned foundation, with encryption in transit and at rest, granular access controls, audit logging, and Business Associate Agreements where applicable, and we support de-identification and governance appropriate for research data. Our architecture handles large datasets on healthcare-grade cloud and harmonizes sources to recognized common data models so analyses are consistent and poolable. We use standards-based interoperability including HL7 and FHIR to integrate clinical data, and we build provenance tracking and reproducible pipelines because defensible evidence requires knowing exactly how it was produced. Where machine learning contributes, we apply it within sound methodology and validate it, aligned with our healthcare MLOps practice, rather than substituting it for rigor. We design analyses to confront the limitations of real-world data honestly, because credibility, not volume, is what makes evidence useful.

Taction Software is a US-based healthcare software company founded in 2013, with offices in Chicago, Cheyenne, Austin, and Sacramento. We build healthcare software exclusively, so complex data engineering, interoperability, and compliance are part of our default process rather than afterthoughts. We have delivered more than 200 healthcare projects, including EHR and EMR platforms such as Voyant Health, FDA-registered mobile applications, and behavioral health tools. That data depth is exactly what RWE demands, where harmonizing messy multi-source data and building reproducible, defensible pipelines is the core challenge. We work as a candid, rigor-focused partner, honest about the limitations of real-world data and disciplined about method, rather than overselling volume as if it were evidence. Our leadership brings deep, hands-on expertise, with our CEO contributing more than 20 years of personal experience in software and healthcare technology. Building with Taction means partnering with a team that has repeatedly taken healthcare software from concept to production in regulated settings.

RWE platform pricing depends on scope, data sources, harmonization complexity, and analytics depth. Taction Software scopes each engagement to your goals, and typical ranges are as follows. A focused module or MVP, such as aggregating and harmonizing a limited set of sources to a common data model, generally falls between $40,000 and $80,000. A full RWE platform with multi-source integration, quality and provenance, cohort tooling, and analytics typically ranges from $80,000 to $200,000. Enterprise platforms with many sources, advanced analytics, and regulatory-grade rigor start at $200,000 and up. Because data harmonization is often the largest effort, we scope it explicitly. Final pricing follows a discovery phase that defines sources, questions, and rigor requirements. We provide clear, itemized estimates so you can build a data foundation and expand into advanced studies.